Docoh
Loading...

INGR Ingredion

Filed: 20 May 21, 5:10pm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 19, 2021

 

 

INGREDION INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 1-13397 22-3514823

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

5 Westbrook Corporate Center

Westchester, Illinois

 60154-5749
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (708) 551-2600

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.01 par value per share INGR New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)     As described under Item 5.07 of this report, on May 19, 2021, the stockholders of Ingredion Incorporated (the “Company”) voted at the Company’s 2021 annual meeting of stockholders (the “2021 annual meeting”) to approve an amendment (the “plan amendment”) to the Ingredion Incorporated Stock Incentive Plan (the “plan”) to increase the number of shares of common stock issuable under the plan by 2,500,000 shares.

The Company’s Board of Directors approved the plan amendment, subject to stockholder approval at the 2021 annual meeting, on March 16, 2021. The plan amendment became effective at the time of stockholder approval.

The plan provides for the grant of incentive and nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, bonus stock, and performance shares to employees, officers and directors of the Company or any of its subsidiaries and other eligible service providers.

A copy of the plan, as amended and restated as of May 19, 2021, is filed as Exhibit 10.1 to this report and is incorporated by reference in this Item 5.02. The material terms of the plan as so amended and restated are described in the Company’s definitive proxy statement on Schedule 14A for the 2021 annual meeting filed with the Securities and Exchange Commission on April 7, 2021 (the “2021 proxy statement”).

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

(a)    At the 2021 annual meeting, the Company’s stockholders voted on four proposals. The proposals are described in the 2021 proxy statement.

(b)    As of the record date for the 2021 annual meeting, an aggregate of 67,228,076 shares of the Company’s common stock were outstanding and entitled to vote at the meeting. Each share of common stock is entitled to one vote per share.

The final voting results with respect to each proposal voted upon at the 2021 annual meeting are set forth below.

Proposal 1

The holders of the outstanding shares of the Company’s common stock elected to the Board of Directors of the Company each of the 11 nominees specified in the 2021 proxy statement, based on the following numbers of votes:

 

Name

  For   Against   Abstentions   Broker Non-Votes 

Luis Aranguren-Trellez

   53,950,975    1,199,563    54,598    4,781,909 

David B. Fischer

   54,879,489    271,577    54,070    4,781,909 

Paul Hanrahan

   53,729,151    1,420,811    55,174    4,781,909 

Rhonda L. Jordan

   53,985,499    1,166,917    52,720    4,781,909 

Gregory B. Kenny

   53,271,412    1,875,559    58,165    4,781,909 

Barbara A. Klein

   54,171,018    983,724    50,394    4,781,909 

Victoria J. Reich

   54,804,450    351,463    49,223    4,781,909 

Stephan B. Tanda

   54,875,381    273,421    56,334    4,781,909 

Jorge A. Uribe

   54,789,156    357,687    58,293    4,781,909 

Dwayne A. Wilson

   54,319,807    831,871    53,458    4,781,909 

James P. Zallie

   54,434,715    715,400    55,021    4,781,909 


Each nominee elected to the Board of Directors at the 2021 annual meeting was elected for a term of one year and until his or her successor has been elected and qualified or until the director’s earlier death, resignation or removal.

Proposal 2

The holders of the outstanding shares of the Company’s common stock approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the 2020 proxy statement, based on the following numbers of votes:

 

For  Against  Abstentions  Broker Non-Votes
52,239,241  2,828,680  137,215  4,781,909

Proposal 3

The holders of the outstanding shares of the Company’s common stock ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2021, based on the following numbers of votes:

 

For  Against  Abstentions
58,736,869  1,209,783  40,393

There were no broker non-votes with respect to this proposal.

Proposal 4

The holders of the outstanding shares of the Company’s common stock approved an amendment to the Ingredion Incorporated Stock Incentive Plan to increase the number of shares of common stock issuable under the plan by 2,500,000 shares, based on the following numbers of votes:

 

For  Against  Abstentions  Broker Non-Votes
51,471,549  3,626,201  107,386  4,781,909

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.
  

Description

10.1  Ingredion Incorporated Stock Incentive Plan, as amended and restated as of May 19, 2021.
104  Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 20, 2021  Ingredion Incorporated
  By: 

/s/ Janet M. Bawcom

   

Janet M. Bawcom

Senior Vice President, General Counsel,

Corporate Secretary and Chief Compliance Officer